Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Patrick H. Biggar"'
Autor:
Patrick H. Biggar
Publikováno v:
Dialyse aktuell. 24:404-405
In der Einleitung ihres Reviews gehen die Autoren darauf ein, dass sich bei der Anwendung der WHO-Kriterien für Anämie, nämlich ein Hämoglobinwert von unter 13,0 g/dl bei Männern und von unter 12,0 g/dl bei Frauen, eine der häufigsten Assoziati
Autor:
Patrick H. Biggar, Gheun-Ho Kim
Publikováno v:
Kidney Research and Clinical Practice, Vol 36, Iss 3, Pp 209-223 (2017)
Kidney Research and Clinical Practice
Kidney Research and Clinical Practice
Anemia, complicating the course of chronic kidney disease, is a significant parameter, whether interpreted as subjective impairment or an objective prognostic marker. Renal anemia is predominantly due to relative erythropoietin (EPO) deficiency. EPO
Publikováno v:
Clinical Nephrology. 86:310-318
AIMS The aim of this study was to investigate the effectiveness, safety, and tolerability of iron isomaltoside in routine practical care of iron deficiency anemia (IDA) in patients with chronic renal failure. METHODS The study included 698 patients w
Autor:
Patrick H. Biggar
Publikováno v:
Dialyse aktuell. 24:406-406
Publikováno v:
Oxford Medicine
Chronic kidney disease-mineral and bone disorders (CKD-MBD), calcium, phosphate, and parathyroid hormone are biomarkers of mortality and cardiovascular risk. Hyperphosphataemia is a prominent and pathophysiologically most plausible risk indicator. Ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::515007e1fb5d0727f067e4740bd46ef5
https://doi.org/10.1093/med/9780199592548.003.0109_update_001
https://doi.org/10.1093/med/9780199592548.003.0109_update_001
Publikováno v:
Recent Patents on Biomarkers. 4:53-59
The calcium-sensing receptor is expressed almost ubiquitously throughout the human body, and is essential for calcium homeostasis and is involved in several disease pathomechanisms. Mainly in nephrology, therapeutic compounds acting on the receptor a
Publikováno v:
Nieren- und Hochdruckkrankheiten. 43:126-145
Publikováno v:
Kidney Research and Clinical Practice, Vol 33, Iss 1, Pp 3-8 (2014)
Kidney Research and Clinical Practice
Kidney Research and Clinical Practice
Over the last 15 years, our knowledge and understanding of the underlying mechanisms involved in the regulation of calcium and phosphate homeostasis in chronic kidney disease have advanced dramatically. Contrary to general opinion in the 20th century
Autor:
Hans-Walter Müller, Andras Veres, Renate Klauser-Braun, Markus Ketteler, Patrick H. Biggar, Josef Kovarik, Susanne Seidinger, Helmut Graf
Publikováno v:
Nephron Clinical Practice. 126:39-50
Background: Safety and efficacy of paricalcitol in hemodialysis patients with secondary hyperparathyroidism (sHPT) was investigated under routine clinical practice in German and Austrian dialysis centers. Methods: Hemodialysis patients with sHPT init
Autor:
Markus Ketteler, Patrick H. Biggar
Publikováno v:
Dialyse aktuell. 17:426-436
In den letzten 2 Jahrzehnten hat sich unser Verstandnis fur den menschlichen Kalzium- und Phosphathaushalt wesentlich geandert. Noch vor nicht allzu langer Zeit ging man davon aus, dass eine erhohte Kalziumzufuhr gunstig sei, um einen gesunden Knoche